Hsp90 Regulates a von Hippel Lindau-independent Hypoxia-inducible Factor-1α-degradative Pathway
National Institutes of Health · Center for Cancer Research
Abstract
HIF-1 alpha is a normally labile proangiogenic transcription factor that is stabilized and activated in hypoxia. Although the von Hippel Lindau (VHL) gene product, the ubiquitin ligase responsible for regulating HIF-1 alpha protein levels, efficiently targets HIF-1 alpha for rapid proteasome-dependent degradation under normoxia, HIF-1 alpha is resistant to the destabilizing effects of VHL under hypoxia. HIF-1 alpha also associates with the molecular chaperone Hsp90. To examine the role of Hsp90 in HIF-1 alpha function, we used renal carcinoma cell (RCC) lines that lack functional VHL and express stable HIF-1 alpha protein under normoxia. Geldanamycin (GA), an Hsp90 antagonist, promoted efficient ubiquitination…
Citation impact
- FWCI
- 13.06
- Percentile
- 100%
- References
- 81
Authors
6- JSJennifer S. IsaacsCorresponding
National Institutes of Health, Center for Cancer Research
- YJYunjin Jung
National Institutes of Health, Center for Cancer Research
- EGEdward G. Mimnaugh
Center for Cancer Research, National Institutes of Health
- AMAlfredo Martı́nez
Center for Cancer Research, National Institutes of Health
- FCFrank Cuttitta
Center for Cancer Research, National Institutes of Health
Topics & keywords
- Hsp90
- Hypoxia (environmental)
- Chemistry
- Hypoxia-inducible factors
- Cell biology
- Biochemistry
- Biology
- Gene
- Good health and well-being